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Physiologic features are those of a single right ventricle
with unobstructed pulmonary blood flow into well-
developed pulmonary arteries and a ductus-dependent
systemic circulation. Survival is unlikely without surgi-
cal therapy.2 The pioneering work of Norwood and
associates3,4 has led gradually to widespread surgical
treatment of patients with this malformation. The prin-
ciples are establishment of a permanent communication
between the systemic ventricle and the aorta, relief of
systemic outflow obstruction by augmentation of the
ascending aorta and arch, restriction of pulmonary
blood flow by a modified Blalock-Taussig shunt, and
creation of a large interatrial communication.
Various other cardiac malformations share the fea-
tures of parallel systemic and pulmonary circulations
with hypoplasia or obstruction of the systemic outflow,
H ypoplastic left heart syndrome (HLHS) is charac-terized by normal segmental anatomy, aortic and
mitral valve stenosis or atresia, and hypoplasia of the
left ventricle, ascending aorta, and aortic arch.1
Objective: We compared the Norwood stage I operation for hypoplastic
left heart syndrome and other complex malformations with ductus-
dependent systemic circulation. Methods: A retrospective study of 194
patients who underwent a Norwood stage I palliation between 1990 and
1998 was conducted. Malformations in 131 patients were classified as
hypoplastic left heart syndrome, defined as aortic and mitral atresia or
severe stenosis, normal segmental anatomy, intact ventricular septum,
and hypoplasia of the left ventricle. Sixtythree patients had other
lesions: hypoplastic left ventricle with ventricular septal defect (n = 18),
unbalanced complete atrioventricular canal (n = 9), complex double-
outlet right ventricle (n = 14), double-inlet left ventricle (n = 11), tricus-
pid atresia with transposition of the great arteries (n = 6), and others (n
= 5), including heterotaxia. Results: Operative (>30 days) and 1-year sur-
vivals were lower for patients with hypoplastic left heart syndrome than
for those with other lesions (63.4% vs 81%, P = .008, and 51.2% vs
71.4%, P = .02, respectively). The presence of a nonhypoplastic left ven-
tricle (n = 27) was associated with higher operative and 1-year survivals
(96.3% vs 64.7%, P = .002; 88.9% vs 52.7%, P < .001). A restrictive atri-
al septal defect and prematurity tended to increase mortality across
both groups. Cox proportional hazards regression indicated that a sin-
gle right ventricle was the most important independent predictor of
death (P < .001). Operative mortality for all patients undergoing the
stage I procedure decreased from 38.5% (1990-1994) to 21.4% after
1994 (P = .02). Conclusions: The survival of patients with malformations
other than hypoplastic left heart syndrome after the Norwood proce-
dure is greater than for those with hypoplastic left heart syndrome.
Staged palliation is valid surgical therapy in these patients, with good
results in intermediate follow-up. (J Thorac Cardiovasc Surg 2000;
119:358-67)
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unobstructed pulmonary blood flow, and a ductus-
dependent systemic circulation. In the presence of two
well-developed ventricles and atrioventricular valves,
surgical treatment aims at a two-ventricle repair. In the
absence of one of the two, the Norwood concept of pal-
liation is applicable.
At Children’s Hospital, Boston, a variety of malfor-
mations other than classic HLHS were treated with the
Norwood procedure by creating a pulmonary
artery–aortic anastomosis, relieving arch obstruction,
and providing pulmonary blood flow by a shunt. The
aim of this study was to assess the results of this thera-
py for this heterogeneous subset of patients. To gain
further insights into the pathophysiology, we compared
these results with our experience with the Norwood
procedure in patients with typical HLHS.
Patients and methods
The subjects of this retrospective cohort study were all
patients who underwent the Norwood stage I palliation
between January 1990 and March 1998 at Children’s
Hospital, Boston (n = 194). Patients were excluded in whom
a systemic ventricular outflow was created by a pulmonary-
aortic anastomosis without aortic arch augmentation. All
patients had parallel pulmonary and systemic circulations
with ductus-dependent systemic circulation and unobstructed
pulmonary blood flow. Cardiac morphology was assessed by
review of echocardiographic reports. Typical HLHS was
diagnosed in 131 patients who had normal segmental anato-
my {S,D,S}, intact ventricular septum, aortic and mitral atre-
sia or stenosis, and hypoplasia of the left ventricle. The
Rhodes criteria5 were used to differentiate between patients
with HLHS and those with critical aortic stenosis. Table I
describes the anatomic subgroups with respect to aortic and
mitral valve anatomy. The Norwood procedure was also
applied in a second group of 63 patients with other malfor-
mations associated with systemic outflow obstruction within
the heart and aortic arch obstruction (Table II). Subgroups
were hypoplastic left-sided structures with ventricular septal
defect (VSD) (n = 18); unbalanced complete atrioventricular
canal (n = 9); complex double-outlet right ventricle (n = 14);
double-inlet left ventricle and single left ventricle (n = 11);
tricuspid atresia with transposition of the great arteries (n =
6); and miscellaneous (n = 5), including heterotaxia (poly-
splenia [n = 2] and asplenia [n = 1]). A well-developed mor-
phologically left ventricle was present in 27 of these patients;
nine of those had two good-sized ventricles (1 with complete
atrioventricular canal, 4 with complex double-outlet right
ventricle, 2 with hypoplastic left-sided structures with VSD,
and 2 with miscellaneous malformations). They were not
suitable for a two-ventricle repair because of severe stenosis
or straddling of one atrioventricular valve.
Mean age and weight at operation were 11 ± 22 days
(range 0-210 days, median 5 days) and 3.3 ± 0.6 kg (range 2-
5.9 kg, median 3.3 kg). Age and weight were not significant-
ly different between HLHS and non-HLHS patients (age:
median 5 vs 5 days, 25th percentile 3 vs 3 days, 75th per-
centile 9.5 vs 11.5 days, P = .70, Wilcoxon test; weight: 3.35
vs 3.3 kg, P = .50). Nineteen patients (10%) were older than
3 weeks at operation (10 HLHS and 9 non-HLHS patients, P
= 0.20), 32.3% were female, and 67.7% were male; 29 (15%)
were premature with a gestational age of less than 38 weeks
(HLHS 10.8%, non-HLHS 23.8%, P = 0.017). In 67 patients
(34.4%) the cardiac malformation was diagnosed in utero.
Three patients had trisomy 21 and 6 patients had additional
extracardiac anomalies (3 HLHS and 3 non-HLHS patients).
Eleven patients (5.7%) had a virtually intact atrial septum
or a highly restrictive atrial septal defect (ASD), which was
enlarged in all but one during cardiac catheterization before
surgical palliation. Additional anatomic findings are listed in
Table III. One patient had had an attempt at a two-ventricle
repair with VSD closure and died after a subsequent conver-
sion to a Norwood procedure. None of the other patients had
a previous surgical procedure.
Operative management. The operations were performed
by 8 surgeons during the study period.
Surgical technique consisted of the creation of a free com-
Table I. Subgroups of typical HLHS malformations
Operative deaths Operative survival
Malformation n No. Percent 95% CL
AA/MA 40 15 63 46-77
AA/MS 35 12 64 48-81
AS/MS 53 20 62 48-75
Others 3 1 67 9-100
Total 131 48 63 55-72
HLHS, Hypoplastic left heart syndrome; CL, confidence limits; AA, aortic
atresia; MA, mitral atresia; MS, mitral stenosis; AS, aortic stenosis.
Table II. Pathologic anatomic diagnoses in malfor-
mations other than typical HLHS
Operative deaths Operative survival
Diagnosis n No. Percent 95% CL
Hypoplastic left heart 18 3 83 59-97
structures with VSD
Unbalanced complete 9 3 67 30-93
AV canal
Complex DORV 14 3 79 49-95
DILV, single LV 11 1 91 60-100
Tricuspid atresia 6 0 100 54-100
with TGA
Others (3 heterotaxia) 5 2 60 14-95
Total 63 12 81 69-90
HLHS, Hypoplastic left heart syndrome; VSD, ventricular septal defect;
AV, atrioventricular; DORV, double-outlet right ventricle; DILV, double-
inlet left ventricle; LV, left ventricle; TGA, transposition of the great
arteries.
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munication between the systemic ventricle and the aorta with
a pulmonary-aortic anastomosis and arch augmentation with
a pulmonary (41%) or aortic homograft (52%) or other tech-
niques (7%). Pulmonary blood flow was provided by a mod-
ified Blalock-Taussig shunt of 3 mm (4%), 3.5 mm (85%), 4
mm (10%), or 5 mm (1%). A large interatrial communication
was created in all patients. Modifications of the above surgi-
cal technique were applied if required by anatomic variants.
Cardiopulmonary bypass time was 141 ± 42 minutes and cir-
culatory arrest time was 57 ± 14 minutes. Secondary sternal
closure after the Norwood procedure was frequent.
Postoperative management aimed at achieving balanced
systemic and pulmonary blood flow with a pulmonary/sys-
temic flow ratio of 1:1 by ventilatory management. Carbon
dioxide was not routinely added in the postoperative treat-
ment. Patients were usually extubated 1 or 2 days after ster-
nal closure.
Further surgical therapy included a bidirectional Glenn
anastomosis (stage II) before a fenestrated Fontan operation.
At the time of follow-up 106 patients had undergone a bidi-
rectional Glenn shunt and 69 had undergone Fontan pallia-
tion. Ages were 7.3 ± 3.3 months at the stage II palliation and
27.7 ± 11.2 months at the third stage and were not signifi-
cantly different between patients with and without HLHS (P
= .50 and P = .62, respectively).
Follow-up and statistical analysis. Follow-up was con-
ducted by review of the medical records including postoper-
ative visits at Children’s Hospital. If the patient was seen
elsewhere, the patient’s physicians or guardians were con-
tacted. Patient outcomes included operative, 1-year, and over-
all survival. Operative mortality was defined as survival of
less than 30 days or in-hospital mortality. Follow-up was com-
plete for operative and 1-year survivors except for 2 patients
who were less than 1 year of age at the time of the study.
Differences in the proportion of patients with and without
preoperative, postoperative, and anatomic variables were
compared by χ2 test. Whenever necessary, the Fisher exact
test was used. Z-scores were compared by use of the 2-sam-
ple Student t test. Approximate 95% confidence limits for
binomial proportions were calculated by the Pratt method.6
Actuarial survivals were determined and univariable analysis
was performed with the Kaplan-Meier product-limit method.
Survival curves were compared by the log-rank test. For mul-
tivariable analysis, the Cox proportional-hazards regression
model was used to establish the variables independently asso-
ciated with each outcome. Risk ratios and 95% confidence
intervals were constructed for the significant multivariable
predictors. Final models were derived by the backward step-
wise likelihood procedure with variables having P < .20 in
the univariable analyses entered as candidates into the Cox
model. Statistical analyses was performed with the SAS soft-
ware package (version 6.12, SAS Institute, Cary, NC).
The following variables were analyzed: preoperative data
(age, weight, fetal diagnosis, prematurity, extracardiac anom-
alies); anatomic characteristics (subgroups of HLHS and
non-HLHS, morphology of the ventricle[s]; Z-scores at dif-
ferent levels of the aorta, of the main pulmonary artery, and
of the valves; presence of coarctation of the aorta and inter-
rupted aortic arch, restrictive ASD, coronary anomalies, coro-
nary fistulas, and sinusoids); and operative data (surgeon, dif-
ferent surgical techniques with regard to arch reconstruction
and establishment of pulmonary blood flow, and cardiopul-
monary bypass and circulatory arrest times).
Results
Overall survival. Duration of follow-up ranged from
0 to 96.7 months and was 46.2 ± 3.2 months for the
HLHS patients and 56.3 ± 4.9 months for the group with
other malformations (log-rank test, P = .04). Actuarial
operative, 1-year, and 3-year survivals in the 194 patients
were 69% ± 3%, 58% ± 4%, and 54% ± 4%, respective-
ly. Kaplan-Meier survival analysis indicated a signifi-
cantly shorter mean survival time for HLHS patients
than for non-HLHS patients (45 ± 4 months vs 57 ± 6
months, P = .03, log-rank test). The other significant pre-
dictors included presence of a single right ventricle (P <
.001) and prematurity (P = .01). The Cox proportional-
hazards model indicated that both prematurity (P = .02)
and a single right ventricle (P < .001) were independent
predictors of overall mortality.
There were 60 operative deaths. Causes for mortality
included myocardial ischemia and unbalanced pul-
monary and systemic blood flow resulting in ventricu-
lar or systemic organ failure or severe hypoxemia.
Twenty-six patients died within the first 24 hours after
the operation (20/48 HLHS deaths and 6/12 non-HLHS
deaths). Autopsy reports were available in 15 of these
patients (10 HLHS; 5 non-HLHS); histologic features
Table III. Preoperative cardiac findings
HLHS Non-HLHS P value
No. 131 63
Severe CoA/IAA 42 (32) 44 (70) < .0001
Restrictive ASD 8 (6) 3 (5) .99
Coronary anomalies 8 (6) 5 (8)† .76
Coronary fistulas/ 17 (13) l (2) .008
LV sinusoids
Z-score aortic valve* –2.2 ± 2.4 –1.4 ± 1.2 .01
Z-score ascending aorta –2.1 ± 1.1 –1.2 ± 1.2 <.0001
Z-score ascending aorta –2.3 ± 2.2 –1.1 ± 1.6 <.0001
Z-score transverse arch –2.3 ± 2.4 –2.8 ± 0.8 <.11
Z-score mitral valve* –3.4 ± 2.2 –2.0 ± 2.1 <.0001
Z-score main pulmonary +2.3 ± 1.7 +2.9 ± 1.5 .02
artery
HLHS, Hypoplastic left heart syndrome; CoA, coarctation of the aorta; IAA,
interrupted aortic arch; ASD, atrial septal defect; LV, left ventricle. Plus-minus
values represent the mean and standard deviation. Percentages are shown in
parentheses.
*Values do not include Z-scores of atretic valves.
†Including 2 patients with anomalous left coronary artery from the pulmonary
artery.
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were compatible with myocardial ischemia in 9 HLHS
patients and 1 non-HLHS patient who had an anom-
alous circumflex coronary artery arising from the pul-
monary artery. During the follow-up period, 29 of 134
patients who survived the first-stage palliation died.
Causes of late death and the time of their occurrence
are described in Table IV. Operative mortality for the
bidirectional Glenn procedure was 3.8% (4/106); three
of the operative deaths occurred in patients who were
under the age of 3 months at the time of stage II surgery
(39, 61, and 73 days of age). Mortality for the Fontan
operation was 2.8% (2/69). There was no significant
difference in mortality for patients with or without
HLHS for the stage II and Fontan procedures (P = .99
and P = .15).
Operative mortality. Operative mortality was signif-
icantly lower for patients with lesions other than typi-
cal HLHS (19% vs 36.6%, P = .008, log-rank test) (Fig
1). Actuarial survival was significantly better in
patients with a well-developed morphologically left
ventricle in univariate Kaplan-Meier analysis (P =
.002) and multivariate Cox regression analysis (P =
.01) (Fig 2). Operative survival was 65% for patients
with a single right ventricle, 100% for patients with two
well-developed ventricles, and 95% for patients with a
single morphologically left ventricle (P = .01). The
estimated risk for patients with a single right ventricle
was approximately four times higher (risk ratio = 3.9,
95% confidence intervals = 1.8-9.4) (Table V).
Prematurity and a virtually intact atrial septum or a
highly restrictive ASD were associated with lower
operative survival (χ2 test: P = 0.02 and P = .04;
Kaplan-Meier analysis: P = .17 and P = .1, respective-
ly; Table V). There was no significant difference in sur-
vival between the anatomic subgroups of the HLHS
patients. This finding also applied to the anatomic sub-
groups of the non-HLHS patients.
To test the hypothesis that evolving management of
patients undergoing the Norwood operation influenced
mortality, we divided the patients according to the date
of operation into a group operated on during the first 4
years (1990-1994; n = 109; 83 HLHS and 26 non-
HLHS patients) and a group operated on during the
second 4 years (1995-1998; n = 85; 48 HLHS and 37
non-HLHS patients) of the study period. Operative sur-
vival increased from 61.5% in the first period to 78.6%
for patients in the latter period (P = .01, univariate
Kaplan-Meier analysis; P = .02, multivariate Cox
regression analysis) (Fig 3). Survival improved in the
second study period for HLHS patients (P = .04) and
did not change for the non-HLHS patients (P = .75).
No other variable correlated with operative survival.
Analysis included preoperative data, anatomic charac-
teristics, and operative data.
One-year survival. One-year survival was signifi-
cantly higher for malformations other than typical
HLHS (71% vs 51%, χ2 analysis, P = .03; Kaplan-
Meier, P = .02). Once again, the presence of a well-
developed morphologically left ventricle was a predic-
tor for survival in univariate (P < .001) and multivariate
analysis (P = .008). Patients with a single right ventri-
cle were estimated to have a risk nearly 5-fold higher
for 1-year mortality (risk ratio = 4.8, 95% confidence
intervals = 2.0-12.7) (Table V). Prematurity and a
restrictive ASD at birth impaired survival (P = .04 and
P = .02, respectively, in χ2 analysis; P = .02 and P =
Table IV. Time and causes of late mortality
HLHS Non-HLHS
Cause No. Time after stage I (mo) No. Time after stage I (mo)
Death before BDG procedure
Sudden, unclear 7 1.5, 2.5, 4, 4, 4.5, 4.5, 5 4 1.5, 2, 2, 2.5
Ventricular failure 4 1.5, 2.5, 3,* 3.5 1 1.5
Cardiac catheterization 1 2 0
Lung disease 1 2.5 0
BDG mortality 3 1.5,† 2.5,† 5 1 2†
Death after BDG procedure
Ventricular failure 3 27, 42, 42* 0
Cardiac catheterization 1 12 0
Fontan mortality 0 2 34, 53
Death after Fontan, unclear 0 1 35
Total 20 9
HLHS, Hypoplastic left heart syndrome; BDG, bidirectional Glenn shunt.
*Status after cardiac transplantation.
†Early bidirectional Glenn shunt at less than 3 months of age.
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.20, respectively, in Kaplan-Meier analysis). None of
the other variables, including date of operation, corre-
lated with 1-year survival.
During follow-up, 5 patients underwent cardiac
transplantation with 2 deaths (Table IV). The 3 sur-
vivors had undergone transplantation after the second
step (2 patients) and after the Fontan procedure (1
patient); all patients undergoing transplantation were in
the HLHS group.
Discussion
HLHS is a lethal anomaly if not treated surgically.
The Norwood operation is predominantly an extracar-
diac procedure that can be applied to a variety of mal-
formations regardless of intracardiac anomalies. The
results have improved continuously because of increas-
ing surgical experience and better understanding of the
delicate balancing of pulmonary and systemic blood
flow in the perioperative period, as well as improve-
ments in techniques of cardiopulmonary bypass in
neonates. Operative survival was 69% in our study over
a period of 8 years with significant improvement to
79% after 1994. Further improvement has occurred
beyond the end point of this study. From January to
December 1998, only 1 of 21 patients died after stage I
palliation. A learning curve is expected in the treatment
of these challenging patients and is attributed to
increasing experience both in surgical and in perioper-
ative management. Therefore, concentration of patients
in larger volume centers would seem to be advanta-
geous.7
Early mortality is often due to myocardial ischemia
or imbalance of pulmonary and systemic blood flow
with subsequent organ failure or hypoxemia.8 Mortality
after initial hospital discharge is not insignificant and
reflects the delicately balanced nature of the circulation
in patients after the first step of staged palliation.
Several studies have been performed to identify pre-
dictors of outcome of the Norwood procedure.
Cardiopulmonary bypass time,9 prerepair pH, lower
birth weight and associated noncardiac anomalies,10
severe obstruction to pulmonary venous return,11
diminutive ascending aorta,12 and anatomic subtype,
specifically aortic and mitral atresia,13 have been
demonstrated to impair survival in recent studies. None
of these risk factors, however, has been consistent
Fig 1. Survival after stage I procedure for HLHS and non-HLHS patients. Each step in the curve denotes an event,
and at each event the standard error is indicated by vertical bars. The curves show a sharp decline in survival until
the age of 6 months, at which time the graphs flatten out.
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across all studies. In contrast to our previous reports,13
the size of the aortic root and ascending aorta was not
a predictor of survival in this series. However, mortali-
ty in the first 24 hours after the operation related to
myocardial ischemia seemed to be more frequent in
HLHS patients.
Fig 2. Survival after stage I procedure for patients with a left ventricle and without a left ventricle. The presence
of a morphologically left ventricle was the most important predictor of operative and 1-year survival. LV, Left
ventricle.
Table V. Predictors of outcome
Univariable Kaplan-Meier analysis Multivariable Cox proportional hazards analysis
Variable Association P value Risk ratio 95% CI P value
Operative mortality
HLHS + .008 .34
Single RV + .002 6.0 2.3-27.8 .01
Restrictive ASD + .10 .16
Prematurity + .17 .13
DOS (1990-1994) + .01 2.2 1.3-4.4 .02
One-year mortality
HLHS + .02 .48
Single RV + <.001 4.8 2.0-12.7 .008
Restrictive ASD + .20 .29
Prematurity + .02 2.3 1.5-4.0 .01
DOS (1990-1994) + .08 .23
Overall mortality
HLHS + .03 .65
Single RV + <.001 3.9 1.8-9.4 <.001
Restrictive ASD + .15 .14
Prematurity + .01 2.1 1.3-3.8 .02
DOS (1990-1994) + .07 .22
CI, Confidence interval; HLHS, hypoplastic left heart syndrome; RV, right ventricle; ASD, atrial septal defect; DOS, date of surgery.
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In our study, prematurity and a restrictive ASD tend-
ed to influence operative mortality. With HLHS physi-
ology, restrictive flow across the atrial septum causes
pulmonary venous hypertension. Although catheter-
directed atrial septoplasty is usually performed shortly
after admission, pulmonary vascular resistance may be
increased, making the balance between systemic and
pulmonary blood flow more difficult to achieve in the
early postoperative period.14,15
We compared the outcome of typical HLHS with
that of other malformations with the same pathophys-
iology and found a greater operative and 1-year sur-
vival in the non-HLHS patients. Actuarial survival in
HLHS patients was in the same range as that in
patients with aortic atresia after staged reconstructive
surgery as reported by Jacobs, Blackstone, and
Bailey10 in the multicenter study of the Congenital
Heart Surgeons Society (64%, 50%, and 47% after 1,
12, and 36 months). In that report, survival was high-
er for patients who entered the transplant protocol
(85%, 64%, and 62% after 1, 12, and 36 months) and
is comparable with that of our non-HLHS patient
group.
In our study the presence of a morphologically left
ventricle was the most important predictor of survival
in this time frame, although this has not been a consis-
tent finding in our previous reports.
In the neonatal period and during the first weeks after
birth, the myocardium has the potential for hyperplasia,
which represents real growth of muscle cells.16 This
ability may be different between the right and left ven-
tricles, adding to the improved outcome of stage I pal-
liation in newborn infants with anatomically left ven-
tricles. A tricuspid atrioventricular valve with possibly
associated abnormalities may also contribute to the
limited prognosis of patients with a single right ventri-
cle.17,18 In the presence of two ventricles with ante-
grade flow through the aortic valve or a VSD, the left
ventricle can contribute to cardiac output, thus decreas-
ing the workload of the right ventricle. Different con-
traction patterns of a right ventricle during the cardiac
cycle in the absence of a second ventricle have recent-
ly been described and may also influence outcome.19
In contrast to our findings, Jacobs and coworkers20
described a comparable outcome for non-HLHS and
HLHS patients. However, they used a different classifi-
cation of these complex malformations and did not dis-
tinguish between patients with right, left, or two ven-
tricles. Kanter and colleagues21 also applied the
Norwood concept successfully to patients with variants
Fig 3. Survival after stage I procedure for patients operated on before 1995 and for patients operated on from
1995 to 1998. Increasing experience both in surgical and perioperative management led to the observed improve-
ment in survival.
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of the HLHS. Mosca and associates22 reported an 89%
operative survival for the Norwood procedure in tricus-
pid atresia or double-inlet right ventricle and transposi-
tion of the great arteries with arch anomalies. These
patients represent two subsets of our non-HLHS patient
group with well-developed left ventricles, confirming
its impact on survival. Comparison of the subgroups of
the non-HLHS patients in a larger series would help to
further determine predictors of survival, which might
be eliminated in our analysis by the heterogeneity of
malformations.
Some anatomic subsets of the HLHS and non-HLHS
patients have been considered potential candidates for a
biventricular repair. Tchervenkov and associates23
selected patients with severe hypoplasia of the left-
sided structures but with antegrade flow through the
left side of the heart and performed a biventricular
repair. Steger and coworkers24 combined Norwood and
Rastelli procedures for interrupted aortic arch with
subaortic stenosis. The criteria to opt for a Norwood
procedure in complex malformations are not well
defined. Systematic analysis of mortality for a two-ven-
tricle approach versus a one-ventricle approach is so far
only available for critical aortic stenosis. We consider
the possibility of a biventricular repair whenever feasi-
ble. However, the mortality for single ventricle pallia-
tion after a failed attempt at a two-ventricle repair has
been exceedingly high in our experience, possibly
because of elevation of pulmonary venous pressure.
Thus the decision for a two-ventricle versus a one-ven-
tricle approach must be made accurately early in the
neonatal period.
Biventricular repair after a stage I operation and a sal-
vage Norwood procedure to bridge a period of severe
left ventricular dysfunction has been discussed.19 The
potential of a hypoplastic left ventricle to grow and the
conditions under which this might happen are intrigu-
ing. We have so far not observed remarkable growth of
a hypoplastic left ventricle in any of our patients after
stage I palliation. This may be due at least in part to the
presence of an unrestricted interatrial communication
and the worse compliance of the hypoplastic left ven-
tricle.
In summary, the findings of our study confirm the
validity of the Norwood concept in the treatment of
complex cardiac anomalies with good results at inter-
mediate follow-up.
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Discussion
Dr William I. Norwood (Wilmington, Del). The group
from the Children’s Hospital of Boston has analyzed a cohort
of patients with HLHS and a smaller but very substantial
group of patients with a variety of non-HLHS anatomic
abnormalities, all of whom underwent a similar palliative
operation over an 8-year period. 
Over the years, I have found it more awkward to deal sur-
gically with aortopulmonary relations such as aortic atresia
with transposition of the great arteries and tricuspid atresia.
However, as we evaluated these different anatomic variations
in comparison to HLHS treated with a similar palliative oper-
ation, we never really noticed a consistent difference between
outcomes of those two patient groups. 
It is always difficult to discuss a very diverse set of
patients, and it is difficult to be sure that one is making mean-
ingful inferences even when our statistical packages encour-
age us to infer. The principal conclusion that I hear, at least
on this group of patients, is that non-HLHS patients fare bet-
ter than HLHS patients; having some semblance of a left ven-
tricle is advantageous. 
My difficulty with such information is that I do not know
what to do with it. Do we use it to select patients? Do we
strongly consider transplantation when we are dealing with a
dominant right ventricle? Or do we simply try harder? 
I made a slide comparing some of our data with your data,
to address this particular point, but as I read the first para-
graph in the discussion of this manuscript, I found the point
is made. You state: “HLHS is a lethal anomaly if not treated
surgically. The Norwood operation is predominantly an
extracardiac procedure that can be applied to a variety of mal-
formations regardless of intracardiac anomalies. The results
have improved continuously because of increasing surgical
experience and better understanding of the delicate balancing
of pulmonary and systemic blood flow in the perioperative
period, as well as improvements in techniques of cardiopul-
monary bypass in neonates. Operative survival was 69% in
our study over a period of 8 years with significant improve-
ment to 79% after 1994. Further improvement has occurred
beyond the end point of this study. From January to
December 1998, only 1 of 21 patients died after stage I palli-
ation.” I do not think the right ventricle is getting stronger. I
think you are on the right track. You further state: “A learning
curve is expected in the treatment of these challenging
patients and is attributed to increasing experience both in sur-
gical and in perioperative management.”
Two interesting points came out that I would like to dis-
cuss. I am not sure you can come up with a concrete answer
to these two questions. I noticed that a group of 11 patients
had virtually intact atrial septum or very restrictive atrial sep-
tum, and they had cardiac catheterization and balloon manip-
ulation of the atrial septum preoperatively. We have given up
trying to deal with the virtually intact atrial septum in the
catheterization laboratory because of its relative thickness
and the relative smallness of the left atrium. We actually have
altered the timing of the operation rather than going to the
cardiac catheterization laboratory before surgical interven-
tion. In your 11 patients, do you think it was worthwhile? Did
it favorably influence the outcome and the physiology of the
patients after the operation? 
Second, a number of patients died in the interim between
the initial palliation and bidirectional Glenn procedure. We
continue to use predominantly a 4-mm tube graft or shunt,
and I noticed that you used predominantly a 3.5-mm shunt.
What are your thoughts relating to the interim mortality and
the size of the shunt? How would that influence the interim
mortality? Would it lead patients to an earlier bidirectional
Glenn shunt or obviate interim myocardial dysfunction,
which is probably even worse than increasing cyanosis? 
Dr Daebritz (Boston, Mass). Thank you for your com-
ments. It is interesting that the risk factors for stage I mortal-
ity are inconsistent between different studies. A variable that
reaches significance in one series does not show an influence
in another series. It may be that multiple factors play a role in
the stage I mortality or that we are missing a major con-
founding variable. 
We found a difference in survival of our Norwood patients
with regard to the underlying anatomy; results of other stud-
ies do not confirm this. This might be due to different patient
selection, as it is controversial how to define HLHS and
where to draw the line to non-HLHS anatomy. Additionally,
the group of non-HLHS patients in itself is inhomogeneous,
with only small numbers for each anatomic subgroup.
Therefore, differences in survival between the subgroups
might not be detected by statistical analysis or might be elim-
inated when comparing the whole group of non-HLHS
patients to HLHS patients. Nevertheless, in our series patients
with a well-developed left ventricle had a better survival.
What do we do with this information? We do not think we
can use it for selecting patients for staged palliation or trans-
plantation. We do think, however, that these results are of
importance in borderline patients, in whom a two-ventricle
repair is considered an option. We found a good survival for
the Norwood palliation in these patients. Attempts at a two-
ventricle repair have to compete with these results. A much
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higher mortality would not be acceptable, although some
patients might end up with two-ventricle physiology.
A highly restrictive ASD or a virtually intact atrial septum
causes low cardiac output with severe acidosis and pul-
monary venous hypertension. We prefer stabilizing the
patient before the operation instead of operating with the
patient in poor clinical condition. Blade septostomy has been
performed but carries a high risk of damaging the free atrial
wall. Usually a balloon atrial septoplasty through a separate
hole in the atrial septum is successful. In most cases a stable
preoperative clinical situation without low output and acido-
sis can be accomplished with this strategy.
Regarding the shunt sizes, the current policy at Children’s
Hospital in Boston is to use 3.5-mm shunts. We think that
this creates the best balance between pulmonary and sys-
temic circulation, at least in the early postoperative period.
This might change when the patient grows. The interim
mortality between stage I and stage II is probably due in part
to disturbance of the delicate balance between the two cir-
culations. The bidirectional Glenn shunt leads to a stable
relation of pulmonary and systemic blood flow without
shunt dependence of pulmonary perfusion. Additionally,
volume unloading of the ventricle and higher diastolic sys-
temic pressures with improved coronary perfusion help to
preserve myocardial function. After this step, mortality
decreases sharply. Therefore, the interim mortality after the
stage I operation is related to obstructed flow through the
shunt, ventricular dysfunction, or myocardial ischemia. We
do not have detailed information about the causes of death
in most of the cases, as the patients often die suddenly out-
side the hospital and autopsies are not available. To find out
whether or not shunt size plays a role, we would need a
detailed analysis of each patient dying in that time period.
However, if shunt size was the major cause of this interim
mortality, one would expect to find series with no signifi-
cant mortality between the first two stages. These do not yet
exist. Probably the balanced perfusion of body and lung
under Norwood stage I physiology is so delicate that it can
be disturbed by common conditions like respiratory and
pulmonary infections or fever.
It might be reasonable to try to decrease this mortality by
performing the bidirectional Glenn shunt earlier after the
stage I procedure, for example, with an interval of 3 months.
The 3 patients in our series who had a Glenn shunt at an age
of less than 3 months and who died did not have a shunt-
dependent pulmonary perfusion for 3 months. In these
patients, severe imbalance of pulmonary and systemic blood
flow or myocardial dysfunction forced the surgeon to per-
form the Glenn shunt very early after the stage I procedure.
Performing an elective Glenn operation 3 months after stage
I with the patient in good clinical condition might improve
the results.
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